Fei Fei

1.1k total citations
46 papers, 654 citations indexed

About

Fei Fei is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Fei Fei has authored 46 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Oncology and 12 papers in Genetics. Recurrent topics in Fei Fei's work include Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Lymphoma Diagnosis and Treatment (7 papers). Fei Fei is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Lymphoma Diagnosis and Treatment (7 papers). Fei Fei collaborates with scholars based in United States, China and Germany. Fei Fei's co-authors include Nora Heisterkamp, John Groffen, Michael Schmitt, Yingzhe Yu, Donald Bunjes, Markus Rojewski, Marlies Götz, Anita Schmitt, Hartmut Döhner and Jochen Greiner and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Fei Fei

42 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Fei United States 14 241 229 227 215 113 46 654
Cecilia Muñoz‐Calleja Spain 15 286 1.2× 111 0.5× 199 0.9× 307 1.4× 111 1.0× 41 696
Koshi Akahane Japan 14 217 0.9× 181 0.8× 301 1.3× 99 0.5× 94 0.8× 63 658
Yves Toiron France 13 236 1.0× 251 1.1× 423 1.9× 112 0.5× 135 1.2× 21 823
Milada S. Vala United States 14 261 1.1× 437 1.9× 349 1.5× 208 1.0× 177 1.6× 20 860
Ivan Inigo United States 10 363 1.5× 146 0.6× 225 1.0× 160 0.7× 112 1.0× 21 693
Sophie Derenne France 8 362 1.5× 338 1.5× 418 1.8× 159 0.7× 59 0.5× 11 780
Richard Smykla United States 11 279 1.2× 224 1.0× 202 0.9× 68 0.3× 165 1.5× 16 637
Lisa Kujawski United States 13 164 0.7× 255 1.1× 313 1.4× 208 1.0× 359 3.2× 21 753
Georgios Z. Rassidakis United States 17 414 1.7× 231 1.0× 489 2.2× 234 1.1× 207 1.8× 34 1.0k
Yuji Shimura Japan 15 226 0.9× 227 1.0× 357 1.6× 190 0.9× 100 0.9× 69 704

Countries citing papers authored by Fei Fei

Since Specialization
Citations

This map shows the geographic impact of Fei Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Fei more than expected).

Fields of papers citing papers by Fei Fei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Fei. The network helps show where Fei Fei may publish in the future.

Co-authorship network of co-authors of Fei Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Fei. A scholar is included among the top collaborators of Fei Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Fei. Fei Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fei, Fei, Milhan Telatar, Lisa Chang, et al.. (2025). Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies. International Journal of Molecular Sciences. 26(2). 435–435.
2.
3.
Fei, Fei, Amar Jariwala, Sheeja T. Pullarkat, et al.. (2024). Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. International Journal of Molecular Sciences. 25(18). 10214–10214. 3 indexed citations
4.
Reid, J., Winston Lee, Joo Y. Song, et al.. (2024). Epstein-Barr virus–positive, primary cutaneous marginal zone lymphoma, with transformation: Case report and review of the literature. American Journal of Clinical Pathology. 163(2). 298–312.
5.
Fei, Fei, C. Caporale, Lisa Chang, et al.. (2024). BRAF Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience. International Journal of Molecular Sciences. 25(10). 5183–5183. 1 indexed citations
6.
Fei, Fei, et al.. (2023). Diagnostic impact of RNA-based next-generation sequencing fusion panel for solid tumors: A single-institution experience. American Journal of Clinical Pathology. 161(4). 329–341. 2 indexed citations
7.
Fei, Fei, Gene P. Siegal, & Shi Wei. (2022). Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers. Clinical Breast Cancer. 22(7). e788–e797. 12 indexed citations
8.
Fei, Fei, Gene P. Siegal, & Shi Wei. (2021). Characterization of estrogen receptor-low-positive breast cancer. Breast Cancer Research and Treatment. 188(1). 225–235. 27 indexed citations
9.
Kulkarni, Tejaswini, Vincent G. Valentine, Fei Fei, et al.. (2021). Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations. PLoS ONE. 16(11). e0260345–e0260345. 13 indexed citations
10.
Nam, Hyeyoung, Anirban Kundu, Garrett J. Brinkley, et al.. (2020). PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression. Matrix Biology. 89. 43–58. 20 indexed citations
11.
Fei, Fei, et al.. (2019). Predictability and efficacy of therapeutic plasma exchange for hypertriglyceridemia induced acute pancreatitis. Transfusion and Apheresis Science. 59(2). 102699–102699. 8 indexed citations
12.
Paz, Helicia, Eun Ji Joo, Fei Fei, et al.. (2018). Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008. Journal of Experimental & Clinical Cancer Research. 37(1). 67–67. 33 indexed citations
13.
Sun, Yilin, Le Zhen, Ying Peng, et al.. (2018). Simultaneous determination of gemcitabine prodrug, gemcitabine and its major metabolite 2′, 2′-difluorodeoxyuridine in rat plasma by UFLC-MS/MS. Journal of Chromatography B. 1084. 4–13. 7 indexed citations
14.
Wu, Yuxia, et al.. (2016). Clinic Observation on Idiopathic Throm-Bocytopenic Purpura by Treatment from Spleen. 11(9). 1785. 1 indexed citations
15.
Wang, Pei, Ying Peng, Xiaolan Zhang, et al.. (2016). Liquid Chromatography–Mass Spectrometry/Mass Spectrometry Analysis and Pharmacokinetic Assessment of Ponatinib in Sprague–Dawley Rats. Oncology and Therapy. 4(1). 117–128. 8 indexed citations
16.
Fei, Fei. (2013). Influence of five-state persons in Huangdineijing on obtaining qi. Journal of Beijing University of Traditional Chinese Medicine. 2 indexed citations
17.
Fei, Fei, et al.. (2012). Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib). Molecular Cancer. 11(1). 42–42. 20 indexed citations
18.
Fei, Fei, Canming Chen, Jingyan Xue, et al.. (2012). Efficacy and Safety of Docetaxel Combined With Oxaliplatin as a Neoadjuvant Chemotherapy Regimen for Chinese Triple-Negative Local Advanced Breast Cancer Patients. American Journal of Clinical Oncology. 36(6). 545–551. 12 indexed citations
19.
Fei, Fei, Yingzhe Yu, Anita Schmitt, et al.. (2010). Effects of nilotinib on regulatory T cells: the dose matters. Molecular Cancer. 9(1). 22–22. 22 indexed citations
20.
Fei, Fei, et al.. (2010). Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia. Leukemia. 24(4). 813–820. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cecilia Muñoz‐Calleja Breakdown of academic impact, for papers by Koshi Akahane Breakdown of academic impact, for papers by Yves Toiron Breakdown of academic impact, for papers by Milada S. Vala Breakdown of academic impact, for papers by Ivan Inigo Breakdown of academic impact, for papers by Sophie Derenne Breakdown of academic impact, for papers by Richard Smykla Breakdown of academic impact, for papers by Lisa Kujawski Breakdown of academic impact, for papers by Georgios Z. Rassidakis Breakdown of academic impact, for papers by Yuji Shimura
Rankless by CCL
2026